We are live on ! Find out more
TEVA icon

Teva Pharmaceuticals
TEVA

744 hedge funds and large institutions have $16.6B invested in Teva Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 744 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

44.92% more ownership

Funds ownership: 0% → 44.92% (+45%)

11% more call options, than puts

Call options by funds: $268M | Put options by funds: $242M

Holders
744
Holders Change
+744
Holders Change %
–
% of All Funds
24.28%
Holding in Top 10
32
Holding in Top 10 Change
+32
Holding in Top 10 Change %
% of All Funds
1.04%
New
744
Increased
–
Reduced
–
Closed
–
Calls
$268M
Puts
$242M
Net Calls
+$25.9M
Net Calls Change
+$25.9M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
FWIA
276
Fort Washington Investment Advisors
Ohio
$3.31M +$3.29M +84,361 New
FCI
277
Financial Counselors Inc
Kansas
$3.3M +$3.28M +84,182 New
FCM
278
Frontier Capital Management
Massachusetts
$3.22M +$3.2M +82,080 New
VST
279
Van Strum & Towne
California
$3.2M +$3.18M +81,621 New
TTWM
280
TCV Trust & Wealth Management
Virginia
$3.11M +$3.09M +79,242 New
MI
281
Markston International
New York
$3.08M +$3.06M +78,450 New
CFB
282
Cullen/Frost Bankers
Texas
$3.05M +$3.03M +77,754 New
SM
283
Senvest Management
New York
$3.04M +$3.02M +77,583 New
MIS
284
Morningstar Investment Services
Illinois
$3.03M +$3.01M +77,350 New
PMAM
285
Picton Mahoney Asset Management
Ontario, Canada
$3.02M +$2.99M +76,900 New
BP
286
Banyan Partners
Florida
$2.96M +$2.94M +75,577 New
FCAM
287
F&C Asset Management
United Kingdom
$2.95M +$2.93M +75,288 New
NCMW
288
Northern Capital Management (Wisconsin)
Wisconsin
$2.94M +$2.92M +75,105 New
FMT
289
First Mercantile Trust
Tennessee
$2.94M +$2.92M +75,087 New
Calamos Advisors
290
Calamos Advisors
Illinois
$2.9M +$2.89M +74,119 New
IAM
291
Impax Asset Management
New Hampshire
$2.77M +$2.75M +70,736 New
Chevy Chase Trust
292
Chevy Chase Trust
Maryland
$2.75M +$2.73M +70,051 New
WMSA
293
Weiss Multi-Strategy Advisers
New York
$2.74M +$2.73M +70,000 New
BFS
294
Baskin Financial Services
Ontario, Canada
$2.74M +$2.73M +70,170 New
HTHT
295
Hemenway Trust Hemenway Trust
New Hampshire
$2.73M +$2.71M +69,628 New
Baillie Gifford & Co
296
Baillie Gifford & Co
United Kingdom
$2.72M +$2.7M +69,350 New
UCFA
297
United Capital Financial Advisors
Texas
$2.71M +$2.69M +69,087 New
PRHC
298
P.R. Herzig & Co
New York
$2.7M +$2.68M +68,848 New
BNP Paribas Asset Management
299
BNP Paribas Asset Management
France
$2.68M +$2.66M +68,421 New
MBE
300
Michael B. Elefante
$2.65M +$2.63M +67,545 New
10 11
12
13 14

TEVA Hedge Fund Activity: Q2 2013 in Review

744 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Teva Pharmaceuticals (TEVA) for Q2 2013, worth a combined $16.6B.

Buyers outnumbered sellers: 744 funds opened new TEVA positions and 0 closed out — a net gain of 744 holders — while 0 added to existing stakes and 0 trimmed.

  • 744 institutional investors held Teva Pharmaceuticals (TEVA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $16.6B of Teva Pharmaceuticals stock for Q2 2013.
  • 744 funds opened new Teva Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +744 holders.

Based on aggregated 13F filings for Q2 2013.